Statistics for the Plotted Points |
TERBUTHYLAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 64 | 101% | 15% | 99% | 15% |
Total | 64 | 101% | 15% | 99% | 15% |
Miscellaneous Statistics for the Samples |
TERBUTHYLAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 64 | 98% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 65 | . | |
False Negatives | 1 | 2% | 1 out of 65 |
Not Spiked | 118 | . | |
False Positives | 2 | 2% | 2 out of 118 |
Statistics for the Plotted Points |
HEXAZINONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 63 | 72% | 16% | 71% | 16% |
Total | 63 | 72% | 16% | 71% | 16% |
Miscellaneous Statistics for the Samples |
HEXAZINONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 63 | 98% | Spiked |
Estimated Values | 4 | 6% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 64 | . | |
False Negatives | 1 | 2% | 1 out of 64 |
Not Spiked | 119 | . | |
False Positives | 1 | 1% | 1 out of 119 |
Statistics for the Plotted Points |
SIMAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 58 | 97% | 17% | 96% | 15% |
Total | 58 | 97% | 17% | 96% | 15% |
Miscellaneous Statistics for the Samples |
SIMAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 58 | 97% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 60 | . | |
False Negatives | 2 | 3% | 2 out of 60 |
Not Spiked | 123 | . | |
False Positives | 24 | 20% | 24 out of 123 |
Statistics for the Plotted Points |
PROMETRYN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 57 | 98% | 20% | 96% | 16% |
Total | 57 | 98% | 20% | 96% | 16% |
Miscellaneous Statistics for the Samples |
PROMETRYN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 57 | 97% | Spiked |
Estimated Values | 3 | 5% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 59 | . | |
False Negatives | 2 | 3% | 2 out of 59 |
Not Spiked | 124 | . | |
False Positives | 3 | 2% | 3 out of 124 |
Statistics for the Plotted Points |
PROMETON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 66 | 89% | 17% | 91% | 16% |
Total | 66 | 89% | 17% | 91% | 16% |
Miscellaneous Statistics for the Samples |
PROMETON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 66 | 99% | Spiked |
Estimated Values | 1 | 1% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 67 | . | |
False Negatives | 1 | 1% | 1 out of 67 |
Not Spiked | 116 | . | |
False Positives | 6 | 5% | 6 out of 116 |
Statistics for the Plotted Points |
DEETHYLATRAZINE (DESETHYL ATRAZINE) (2-CHLORO-4-ISOPROPYLAMINO-6-S-TRIAZINE) CIAT |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 58 | 91% | 30% | 90% | 33% |
Total | 58 | 91% | 30% | 90% | 33% |
Miscellaneous Statistics for the Samples |
DEETHYLATRAZINE (DESETHYL ATRAZINE) (2-CHLORO-4-ISOPROPYLAMINO-6-S-TRIAZINE) CIAT |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 58 | 97% | Spiked |
Estimated Values | 58 | 97% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 60 | . | |
False Negatives | 2 | 3% | 2 out of 60 |
Not Spiked | 123 | . | |
False Positives | 2 | 2% | 2 out of 123 |
Statistics for the Plotted Points |
CYANAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 57 | 95% | 21% | 96% | 19% |
Total | 57 | 95% | 21% | 96% | 19% |
Miscellaneous Statistics for the Samples |
CYANAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 57 | 93% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 4 | 7% | 4 out of 61 |
Not Spiked | 122 | . | |
False Positives | 3 | 2% | 3 out of 122 |
Statistics for the Plotted Points |
FONOFOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 55 | 79% | 23% | 84% | 16% |
Total | 55 | 79% | 23% | 84% | 16% |
Miscellaneous Statistics for the Samples |
FONOFOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 55 | 92% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 60 | . | |
False Negatives | 5 | 8% | 5 out of 60 |
Not Spiked | 123 | . | |
False Positives | 1 | 1% | 1 out of 123 |
Statistics for the Plotted Points |
ALPHA-ENDOSULFAN (ENDOSULFAN I) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 63 | 92% | 17% | 89% | 14% |
Total | 63 | 92% | 17% | 89% | 14% |
Miscellaneous Statistics for the Samples |
ALPHA-ENDOSULFAN (ENDOSULFAN I) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 63 | 97% | Spiked |
Estimated Values | 3 | 5% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 65 | . | |
False Negatives | 2 | 3% | 2 out of 65 |
Not Spiked | 118 | . | |
False Positives | 2 | 2% | 2 out of 118 |
Statistics for the Plotted Points |
DICROTOPHOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 14 | 46% | 14% | 44% | 9% |
>= Reporting Level | 51 | 29% | 13% | 29% | 16% |
Total | 65 | 33% | 15% | 32% | 17% |
Miscellaneous Statistics for the Samples |
DICROTOPHOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 65 | 97% | Spiked |
Estimated Values | 65 | 97% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 67 | . | |
False Negatives | 2 | 3% | 2 out of 67 |
Not Spiked | 116 | . | |
False Positives | 3 | 3% | 3 out of 116 |
Statistics for the Plotted Points |
DICHLOROVOS (DICHLORVOS) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 12 | 79% | 19% | 76% | 19% |
>= Reporting Level | 52 | 34% | 24% | 29% | 22% |
Total | 64 | 42% | 29% | 32% | 36% |
Miscellaneous Statistics for the Samples |
DICHLOROVOS (DICHLORVOS) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 64 | 96% | Spiked |
Estimated Values | 64 | 96% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 67 | . | |
False Negatives | 3 | 4% | 3 out of 67 |
Not Spiked | 116 | . | |
False Positives | 2 | 2% | 2 out of 116 |
Statistics for the Plotted Points |
CHLORPYRIFOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 112% | 14% | 112% | 14% |
>= Reporting Level | 56 | 80% | 22% | 80% | 17% |
Total | 58 | 81% | 22% | 81% | 17% |
Miscellaneous Statistics for the Samples |
CHLORPYRIFOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 58 | 97% | Spiked |
Estimated Values | 3 | 5% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 60 | . | |
False Negatives | 1 | 2% | 1 out of 60 |
Not Spiked | 123 | . | |
False Positives | 2 | 2% | 2 out of 123 |
Statistics for the Plotted Points |
DIELDRIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 65 | 98% | 19% | 95% | 16% |
Total | 65 | 98% | 19% | 95% | 16% |
Miscellaneous Statistics for the Samples |
DIELDRIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 65 | 98% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 66 | . | |
False Negatives | 1 | 2% | 1 out of 66 |
Not Spiked | 117 | . | |
False Positives | 1 | 1% | 1 out of 117 |
Statistics for the Plotted Points |
METOLACHLOR |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 66 | 99% | 21% | 95% | 16% |
Total | 66 | 99% | 21% | 95% | 16% |
Miscellaneous Statistics for the Samples |
METOLACHLOR |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 66 | 99% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 67 | . | |
False Negatives | 1 | 1% | 1 out of 67 |
Not Spiked | 116 | . | |
False Positives | 2 | 2% | 2 out of 116 |
Statistics for the Plotted Points |
MALATHION |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 58 | 91% | 22% | 90% | 18% |
Total | 58 | 91% | 22% | 90% | 18% |
Miscellaneous Statistics for the Samples |
MALATHION |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 58 | 97% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 60 | . | |
False Negatives | 2 | 3% | 2 out of 60 |
Not Spiked | 123 | . | |
False Positives | 2 | 2% | 2 out of 123 |
Statistics for the Plotted Points |
DIAZINON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 57 | 96% | 16% | 101% | 15% |
Total | 57 | 96% | 16% | 101% | 15% |
Miscellaneous Statistics for the Samples |
DIAZINON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 57 | 97% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 59 | . | |
False Negatives | 2 | 3% | 2 out of 59 |
Not Spiked | 124 | . | |
False Positives | 2 | 2% | 2 out of 124 |
Statistics for the Plotted Points |
ATRAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 64 | 101% | 14% | 104% | 15% |
Total | 64 | 101% | 14% | 104% | 15% |
Miscellaneous Statistics for the Samples |
ATRAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 64 | 98% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 65 | . | |
False Negatives | 1 | 2% | 1 out of 65 |
Not Spiked | 118 | . | |
False Positives | 3 | 3% | 3 out of 118 |
Statistics for the Plotted Points |
ALACHLOR |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 58 | 98% | 17% | 97% | 18% |
Total | 58 | 98% | 17% | 97% | 18% |
Miscellaneous Statistics for the Samples |
ALACHLOR |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 58 | 97% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 60 | . | |
False Negatives | 2 | 3% | 2 out of 60 |
Not Spiked | 123 | . | |
False Positives | 2 | 2% | 2 out of 123 |
Statistics for the Plotted Points |
ACETOCHLOR |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 59 | 98% | 16% | 100% | 16% |
Total | 59 | 98% | 16% | 100% | 16% |
Miscellaneous Statistics for the Samples |
ACETOCHLOR |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 59 | 97% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 2 | 3% | 2 out of 61 |
Not Spiked | 122 | . | |
False Positives | 2 | 2% | 2 out of 122 |
Statistics for the Plotted Points |
1-NAPHTHOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 78% | . | 78% | 0% |
>= Reporting Level | 64 | 67% | 44% | 58% | 50% |
Total | 65 | 67% | 44% | 58% | 50% |
Miscellaneous Statistics for the Samples |
1-NAPHTHOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 65 | 97% | Spiked |
Estimated Values | 65 | 97% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 67 | . | |
False Negatives | 2 | 3% | 2 out of 67 |
Not Spiked | 116 | . | |
False Positives | 2 | 2% | 2 out of 116 |
Statistics for the Plotted Points |
CYFLUTHRIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 54 | 58% | 18% | 56% | 17% |
Total | 54 | 58% | 18% | 56% | 17% |
Miscellaneous Statistics for the Samples |
CYFLUTHRIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 54 | 82% | Spiked |
Estimated Values | 54 | 82% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 66 | . | |
False Negatives | 12 | 18% | 12 out of 66 |
Not Spiked | 117 | . | |
False Positives | 2 | 2% | 2 out of 117 |
Statistics for the Plotted Points |
CYPERMETHRIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 64 | 63% | 16% | 61% | 16% |
Total | 64 | 63% | 16% | 61% | 16% |
Miscellaneous Statistics for the Samples |
CYPERMETHRIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 64 | 97% | Spiked |
Estimated Values | 64 | 97% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 66 | . | |
False Negatives | 2 | 3% | 2 out of 66 |
Not Spiked | 117 | . | |
False Positives | 2 | 2% | 2 out of 117 |
Statistics for the Plotted Points |
ENDOSULFAN SULFATE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 59 | 87% | 14% | 89% | 15% |
Total | 59 | 87% | 14% | 89% | 15% |
Miscellaneous Statistics for the Samples |
ENDOSULFAN SULFATE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 59 | 97% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 2 | 3% | 2 out of 61 |
Not Spiked | 122 | . | |
False Positives | 2 | 2% | 2 out of 122 |
Statistics for the Plotted Points |
FENAMIPHOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 114% | . | 114% | 0% |
>= Reporting Level | 64 | 89% | 21% | 87% | 18% |
Total | 65 | 89% | 21% | 87% | 18% |
Miscellaneous Statistics for the Samples |
FENAMIPHOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 65 | 97% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 67 | . | |
False Negatives | 2 | 3% | 2 out of 67 |
Not Spiked | 116 | . | |
False Positives | 3 | 3% | 3 out of 116 |
Statistics for the Plotted Points |
IPRODIONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 55 | 68% | 25% | 75% | 18% |
Total | 55 | 68% | 25% | 75% | 18% |
Miscellaneous Statistics for the Samples |
IPRODIONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 55 | 83% | Spiked |
Estimated Values | 55 | 83% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 66 | . | |
False Negatives | 11 | 17% | 11 out of 66 |
Not Spiked | 117 | . | |
False Positives | 1 | 1% | 1 out of 117 |
Statistics for the Plotted Points |
ISOFENPHOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 63 | 103% | 25% | 103% | 23% |
Total | 63 | 103% | 25% | 103% | 23% |
Miscellaneous Statistics for the Samples |
ISOFENPHOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 63 | 97% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 65 | . | |
False Negatives | 2 | 3% | 2 out of 65 |
Not Spiked | 118 | . | |
False Positives | 2 | 2% | 2 out of 118 |
Statistics for the Plotted Points |
CYHALOTHRIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 56 | 46% | 20% | 48% | 23% |
Total | 56 | 46% | 20% | 48% | 23% |
Miscellaneous Statistics for the Samples |
CYHALOTHRIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 56 | 93% | Spiked |
Estimated Values | 56 | 93% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 60 | . | |
False Negatives | 4 | 7% | 4 out of 60 |
Not Spiked | 123 | . | |
False Positives | 2 | 2% | 2 out of 123 |
Statistics for the Plotted Points |
METALAXYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 64 | 98% | 17% | 97% | 16% |
Total | 64 | 98% | 17% | 97% | 16% |
Miscellaneous Statistics for the Samples |
METALAXYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 64 | 98% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 65 | . | |
False Negatives | 1 | 2% | 1 out of 65 |
Not Spiked | 118 | . | |
False Positives | 1 | 1% | 1 out of 118 |
Statistics for the Plotted Points |
METHIDATHION (SUPRACIDE) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 63 | 90% | 19% | 85% | 18% |
Total | 63 | 90% | 19% | 85% | 18% |
Miscellaneous Statistics for the Samples |
METHIDATHION (SUPRACIDE) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 63 | 97% | Spiked |
Estimated Values | 3 | 5% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 65 | . | |
False Negatives | 2 | 3% | 2 out of 65 |
Not Spiked | 118 | . | |
False Positives | 2 | 2% | 2 out of 118 |
Statistics for the Plotted Points |
MYCLOBUTANIL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 65 | 82% | 17% | 79% | 17% |
Total | 65 | 82% | 17% | 79% | 17% |
Miscellaneous Statistics for the Samples |
MYCLOBUTANIL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 65 | 98% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 66 | . | |
False Negatives | 1 | 2% | 1 out of 66 |
Not Spiked | 117 | . | |
False Positives | 1 | 1% | 1 out of 117 |
Statistics for the Plotted Points |
OXYFLUORFEN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 56 | 81% | 21% | 78% | 19% |
Total | 56 | 81% | 21% | 78% | 19% |
Miscellaneous Statistics for the Samples |
OXYFLUORFEN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 56 | 97% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 58 | . | |
False Negatives | 2 | 3% | 2 out of 58 |
Not Spiked | 125 | . | |
False Positives | 2 | 2% | 2 out of 125 |
Statistics for the Plotted Points |
PHOSMET (IMIDAN) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 16 | 84% | 43% | 92% | 58% |
>= Reporting Level | 34 | 51% | 20% | 55% | 18% |
Total | 50 | 62% | 33% | 56% | 24% |
Miscellaneous Statistics for the Samples |
PHOSMET (IMIDAN) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 50 | 74% | Spiked |
Estimated Values | 50 | 74% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 9 | 13% | Spiked |
Spiked | 68 | . | |
False Negatives | 9 | 13% | 9 out of 68 |
Not Spiked | 115 | . | |
False Positives | 2 | 2% | 2 out of 115 |
Statistics for the Plotted Points |
TEFLUTHRIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 136% | 63% | 131% | 89% |
>= Reporting Level | 54 | 69% | 29% | 65% | 12% |
Total | 59 | 75% | 37% | 67% | 14% |
Miscellaneous Statistics for the Samples |
TEFLUTHRIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 59 | 97% | Spiked |
Estimated Values | 59 | 97% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 61 | . | |
False Negatives | 1 | 2% | 1 out of 61 |
Not Spiked | 122 | . | |
False Positives | 3 | 2% | 3 out of 122 |
Statistics for the Plotted Points |
TRIBUFOS (S,S,S-TRIBUTYLPHOSPHOROTRITHIOATE (DEF)) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 65 | 63% | 16% | 58% | 16% |
Total | 65 | 63% | 16% | 58% | 16% |
Miscellaneous Statistics for the Samples |
TRIBUFOS (S,S,S-TRIBUTYLPHOSPHOROTRITHIOATE (DEF)) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 65 | 97% | Spiked |
Estimated Values | 65 | 97% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 67 | . | |
False Negatives | 2 | 3% | 2 out of 67 |
Not Spiked | 116 | . | |
False Positives | 10 | 9% | 10 out of 116 |
Statistics for the Plotted Points |
2-CHLORO-2,6-DIETHYLACETANILIDE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 46 | 104% | 16% | 103% | 12% |
Total | 46 | 104% | 16% | 103% | 12% |
Miscellaneous Statistics for the Samples |
2-CHLORO-2,6-DIETHYLACETANILIDE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 46 | 98% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 47 | . | |
False Negatives | 1 | 2% | 1 out of 47 |
Not Spiked | 136 | . | |
False Positives | 1 | 1% | 1 out of 136 |
Statistics for the Plotted Points |
2-ETHYL-6-METHYLANILINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 51 | 84% | 26% | 91% | 8% |
Total | 51 | 84% | 26% | 91% | 8% |
Miscellaneous Statistics for the Samples |
2-ETHYL-6-METHYLANILINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 51 | 98% | Spiked |
Estimated Values | 51 | 98% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 52 | . | |
False Negatives | 1 | 2% | 1 out of 52 |
Not Spiked | 131 | . | |
False Positives | 0 | 0% | 0 out of 131 |
Statistics for the Plotted Points |
3,4-DICHLOROANILINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 56 | 83% | 10% | 82% | 10% |
Total | 56 | 83% | 10% | 82% | 10% |
Miscellaneous Statistics for the Samples |
3,4-DICHLOROANILINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 56 | 95% | Spiked |
Estimated Values | 56 | 95% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 59 | . | |
False Negatives | 2 | 3% | 2 out of 59 |
Not Spiked | 124 | . | |
False Positives | 2 | 2% | 2 out of 124 |
Statistics for the Plotted Points |
3,5-DICHLOROANILINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 64 | 93% | 8% | 93% | 7% |
Total | 64 | 93% | 8% | 93% | 7% |
Miscellaneous Statistics for the Samples |
3,5-DICHLOROANILINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 64 | 98% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 65 | . | |
False Negatives | 1 | 2% | 1 out of 65 |
Not Spiked | 118 | . | |
False Positives | 3 | 3% | 3 out of 118 |
Statistics for the Plotted Points |
4-CHLORO-2-METHYLPHENOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 57 | 69% | 11% | 69% | 12% |
Total | 57 | 69% | 11% | 69% | 12% |
Miscellaneous Statistics for the Samples |
4-CHLORO-2-METHYLPHENOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 57 | 97% | Spiked |
Estimated Values | 57 | 97% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 59 | . | |
False Negatives | 2 | 3% | 2 out of 59 |
Not Spiked | 124 | . | |
False Positives | 2 | 2% | 2 out of 124 |
Statistics for the Plotted Points |
AZINPHOS-METHYL-OXON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 3 | 81% | 46% | 82% | 68% |
>= Reporting Level | 37 | 68% | 25% | 66% | 25% |
Total | 40 | 69% | 26% | 67% | 28% |
Miscellaneous Statistics for the Samples |
AZINPHOS-METHYL-OXON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 95% | Spiked |
Estimated Values | 40 | 95% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 42 | . | |
False Negatives | 1 | 2% | 1 out of 42 |
Not Spiked | 141 | . | |
False Positives | 1 | 1% | 1 out of 141 |
Statistics for the Plotted Points |
CHLORPYRIFOS, OXYGEN ANALOG |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 8 | 67% | 25% | 69% | 28% |
>= Reporting Level | 35 | 42% | 30% | 31% | 31% |
Total | 43 | 46% | 30% | 33% | 38% |
Miscellaneous Statistics for the Samples |
CHLORPYRIFOS, OXYGEN ANALOG |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 43 | 64% | Spiked |
Estimated Values | 43 | 64% | Spiked |
Deleted Values | 3 | 2% | Spiked + Not Spiked |
Spiked, Censored | 3 | 4% | Spiked |
Spiked | 67 | . | |
False Negatives | 21 | 31% | 21 out of 67 |
Not Spiked | 116 | . | |
False Positives | 3 | 3% | 3 out of 113 |
Statistics for the Plotted Points |
DIAZINON, OXYGEN ANALOG |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 51 | 82% | 23% | 80% | 23% |
Total | 51 | 82% | 23% | 80% | 23% |
Miscellaneous Statistics for the Samples |
DIAZINON, OXYGEN ANALOG |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 51 | 86% | Spiked |
Estimated Values | 4 | 7% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 59 | . | |
False Negatives | 7 | 12% | 7 out of 59 |
Not Spiked | 124 | . | |
False Positives | 3 | 2% | 3 out of 124 |
Statistics for the Plotted Points |
DISULFOTON SULFONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 53 | 88% | 19% | 88% | 13% |
Total | 53 | 88% | 19% | 88% | 13% |
Miscellaneous Statistics for the Samples |
DISULFOTON SULFONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 53 | 96% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 55 | . | |
False Negatives | 2 | 4% | 2 out of 55 |
Not Spiked | 128 | . | |
False Positives | 2 | 2% | 2 out of 128 |
Statistics for the Plotted Points |
ETHION MONOXON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 17 | 94% | 19% | 83% | 22% |
Total | 17 | 94% | 19% | 83% | 22% |
Miscellaneous Statistics for the Samples |
ETHION MONOXON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 17 | 100% | Spiked |
Estimated Values | 17 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 17 | . | |
False Negatives | 0 | 0% | 0 out of 17 |
Not Spiked | 166 | . | |
False Positives | 6 | 4% | 6 out of 166 |
Statistics for the Plotted Points |
FENAMIPHOS SULFONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 6 | 108% | 49% | 97% | 41% |
>= Reporting Level | 59 | 87% | 22% | 87% | 28% |
Total | 65 | 89% | 25% | 87% | 27% |
Miscellaneous Statistics for the Samples |
FENAMIPHOS SULFONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 65 | 97% | Spiked |
Estimated Values | 18 | 27% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 67 | . | |
False Negatives | 2 | 3% | 2 out of 67 |
Not Spiked | 116 | . | |
False Positives | 2 | 2% | 2 out of 116 |
Statistics for the Plotted Points |
FENAMIPHOS SULFOXIDE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 13 | 37% | 23% | 34% | 20% |
>= Reporting Level | 46 | 24% | 11% | 23% | 11% |
Total | 59 | 27% | 15% | 25% | 13% |
Miscellaneous Statistics for the Samples |
FENAMIPHOS SULFOXIDE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 59 | 89% | Spiked |
Estimated Values | 59 | 89% | Spiked |
Deleted Values | 2 | 1% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 67 | . | |
False Negatives | 6 | 9% | 6 out of 66 |
Not Spiked | 116 | . | |
False Positives | 5 | 4% | 5 out of 115 |
Statistics for the Plotted Points |
MALAOXON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 8 | 101% | 20% | 101% | 25% |
>= Reporting Level | 57 | 83% | 22% | 84% | 17% |
Total | 65 | 85% | 22% | 85% | 17% |
Miscellaneous Statistics for the Samples |
MALAOXON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 65 | 97% | Spiked |
Estimated Values | 14 | 21% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 67 | . | |
False Negatives | 2 | 3% | 2 out of 67 |
Not Spiked | 116 | . | |
False Positives | 3 | 3% | 3 out of 116 |
Statistics for the Plotted Points |
PARAOXON-METHYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 57 | 86% | 26% | 81% | 27% |
Total | 57 | 86% | 26% | 81% | 27% |
Miscellaneous Statistics for the Samples |
PARAOXON-METHYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 57 | 95% | Spiked |
Estimated Values | 57 | 95% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 60 | . | |
False Negatives | 3 | 5% | 3 out of 60 |
Not Spiked | 123 | . | |
False Positives | 2 | 2% | 2 out of 123 |
Statistics for the Plotted Points |
PHORATE OXON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 118% | . | 118% | 0% |
>= Reporting Level | 46 | 96% | 25% | 94% | 29% |
Total | 47 | 96% | 25% | 95% | 30% |
Miscellaneous Statistics for the Samples |
PHORATE OXON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 47 | 100% | Spiked |
Estimated Values | 47 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 47 | . | |
False Negatives | 0 | 0% | 0 out of 47 |
Not Spiked | 136 | . | |
False Positives | 0 | 0% | 0 out of 136 |
Statistics for the Plotted Points |
PHOSMET OXON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 42% | 23% | 34% | 18% |
>= Reporting Level | 21 | 75% | 50% | 70% | 47% |
Total | 26 | 69% | 48% | 55% | 47% |
Miscellaneous Statistics for the Samples |
PHOSMET OXON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 26 | 65% | Spiked |
Estimated Values | 26 | 65% | Spiked |
Deleted Values | 10 | 5% | Spiked + Not Spiked |
Spiked, Censored | 1 | 3% | Spiked |
Spiked | 42 | . | |
False Negatives | 13 | 33% | 13 out of 40 |
Not Spiked | 141 | . | |
False Positives | 0 | 0% | 0 out of 133 |
Statistics for the Plotted Points |
TERBUFOS-O-ANALOGUE SULFONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 99% | 18% | 105% | 16% |
>= Reporting Level | 13 | 97% | 25% | 96% | 16% |
Total | 17 | 97% | 23% | 99% | 16% |
Miscellaneous Statistics for the Samples |
TERBUFOS-O-ANALOGUE SULFONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 17 | 100% | Spiked |
Estimated Values | 1 | 6% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 17 | . | |
False Negatives | 0 | 0% | 0 out of 17 |
Not Spiked | 166 | . | |
False Positives | 0 | 0% | 0 out of 166 |
Statistics for the Plotted Points |
FIPRONIL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 81 | 96% | 23% | 93% | 21% |
Total | 81 | 96% | 23% | 93% | 21% |
Miscellaneous Statistics for the Samples |
FIPRONIL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 81 | 98% | Spiked |
Estimated Values | 81 | 98% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 83 | . | |
False Negatives | 2 | 2% | 2 out of 83 |
Not Spiked | 100 | . | |
False Positives | 5 | 5% | 5 out of 100 |
Statistics for the Plotted Points |
FIPRONIL SULFIDE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 59 | 98% | 27% | 99% | 20% |
Total | 59 | 98% | 27% | 99% | 20% |
Miscellaneous Statistics for the Samples |
FIPRONIL SULFIDE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 59 | 98% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 60 | . | |
False Negatives | 1 | 2% | 1 out of 60 |
Not Spiked | 123 | . | |
False Positives | 35 | 28% | 35 out of 123 |
Statistics for the Plotted Points |
FIPRONIL SULFONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 59 | 77% | 23% | 75% | 23% |
Total | 59 | 77% | 23% | 75% | 23% |
Miscellaneous Statistics for the Samples |
FIPRONIL SULFONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 59 | 97% | Spiked |
Estimated Values | 6 | 10% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 2 | 3% | 2 out of 61 |
Not Spiked | 122 | . | |
False Positives | 21 | 17% | 21 out of 122 |
Statistics for the Plotted Points |
DESULFINYLFIPRONIL AMIDE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 144% | . | 144% | 0% |
>= Reporting Level | 16 | 98% | 26% | 100% | 27% |
Total | 17 | 101% | 28% | 101% | 25% |
Miscellaneous Statistics for the Samples |
DESULFINYLFIPRONIL AMIDE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 17 | 100% | Spiked |
Estimated Values | 16 | 94% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 17 | . | |
False Negatives | 0 | 0% | 0 out of 17 |
Not Spiked | 166 | . | |
False Positives | 0 | 0% | 0 out of 166 |
Statistics for the Plotted Points |
DESULFINYLFIPRONIL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 52 | 90% | 24% | 91% | 25% |
Total | 52 | 90% | 24% | 91% | 25% |
Miscellaneous Statistics for the Samples |
DESULFINYLFIPRONIL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 52 | 100% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 52 | . | |
False Negatives | 0 | 0% | 0 out of 52 |
Not Spiked | 131 | . | |
False Positives | 1 | 1% | 1 out of 131 |
Statistics for the Plotted Points |
TEBUCONAZOLE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 40 | 58% | 15% | 56% | 13% |
Total | 40 | 58% | 15% | 56% | 13% |
Miscellaneous Statistics for the Samples |
TEBUCONAZOLE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 98% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 41 | . | |
False Negatives | 1 | 2% | 1 out of 41 |
Not Spiked | 142 | . | |
False Positives | 1 | 1% | 1 out of 142 |
Statistics for the Plotted Points |
CIS-PROPICONAZOLE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 179% | . | 179% | 0% |
>= Reporting Level | 24 | 99% | 46% | 100% | 65% |
Total | 25 | 102% | 48% | 102% | 67% |
Miscellaneous Statistics for the Samples |
CIS-PROPICONAZOLE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 25 | 100% | Spiked |
Estimated Values | 25 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 25 | . | |
False Negatives | 0 | 0% | 0 out of 25 |
Not Spiked | 158 | . | |
False Positives | 0 | 0% | 0 out of 158 |
Statistics for the Plotted Points |
TRANS-PROPICONAZOLE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 25 | 85% | 16% | 83% | 11% |
Total | 25 | 85% | 16% | 83% | 11% |
Miscellaneous Statistics for the Samples |
TRANS-PROPICONAZOLE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 25 | 100% | Spiked |
Estimated Values | 25 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 25 | . | |
False Negatives | 0 | 0% | 0 out of 25 |
Not Spiked | 158 | . | |
False Positives | 0 | 0% | 0 out of 158 |
Statistics for the Plotted Points |
ETHION |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 59 | 85% | 18% | 82% | 18% |
Total | 59 | 85% | 18% | 82% | 18% |
Miscellaneous Statistics for the Samples |
ETHION |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 59 | 98% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 60 | . | |
False Negatives | 1 | 2% | 1 out of 60 |
Not Spiked | 123 | . | |
False Positives | 1 | 1% | 1 out of 123 |
Statistics for the Plotted Points |
METRIBUZIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 65 | 89% | 18% | 87% | 18% |
Total | 65 | 89% | 18% | 87% | 18% |
Miscellaneous Statistics for the Samples |
METRIBUZIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 65 | 97% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 67 | . | |
False Negatives | 2 | 3% | 2 out of 67 |
Not Spiked | 116 | . | |
False Positives | 2 | 2% | 2 out of 116 |
Statistics for the Plotted Points |
2,6-DIETHYLANILINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 55 | 95% | 24% | 99% | 13% |
Total | 55 | 95% | 24% | 99% | 13% |
Miscellaneous Statistics for the Samples |
2,6-DIETHYLANILINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 55 | 93% | Spiked |
Estimated Values | 7 | 12% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 59 | . | |
False Negatives | 4 | 7% | 4 out of 59 |
Not Spiked | 124 | . | |
False Positives | 1 | 1% | 1 out of 124 |
Statistics for the Plotted Points |
TRIFLURALIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 9 | 128% | 17% | 125% | 12% |
>= Reporting Level | 51 | 95% | 21% | 98% | 22% |
Total | 60 | 100% | 23% | 101% | 20% |
Miscellaneous Statistics for the Samples |
TRIFLURALIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 60 | 98% | Spiked |
Estimated Values | 4 | 7% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 1 | 2% | 1 out of 61 |
Not Spiked | 122 | . | |
False Positives | 1 | 1% | 1 out of 122 |
Statistics for the Plotted Points |
DIMETHOATE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 58 | 49% | 17% | 47% | 16% |
Total | 58 | 49% | 17% | 47% | 16% |
Miscellaneous Statistics for the Samples |
DIMETHOATE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 58 | 98% | Spiked |
Estimated Values | 58 | 98% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 59 | . | |
False Negatives | 1 | 2% | 1 out of 59 |
Not Spiked | 124 | . | |
False Positives | 1 | 1% | 1 out of 124 |
Statistics for the Plotted Points |
PHORATE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 59 | 77% | 15% | 81% | 15% |
Total | 59 | 77% | 15% | 81% | 15% |
Miscellaneous Statistics for the Samples |
PHORATE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 59 | 97% | Spiked |
Estimated Values | 4 | 7% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 2 | 3% | 2 out of 61 |
Not Spiked | 122 | . | |
False Positives | 2 | 2% | 2 out of 122 |
Statistics for the Plotted Points |
PARATHION-METHYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 65 | 91% | 22% | 88% | 17% |
Total | 65 | 91% | 22% | 88% | 17% |
Miscellaneous Statistics for the Samples |
PARATHION-METHYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 65 | 98% | Spiked |
Estimated Values | 4 | 6% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 66 | . | |
False Negatives | 1 | 2% | 1 out of 66 |
Not Spiked | 117 | . | |
False Positives | 1 | 1% | 1 out of 117 |
Statistics for the Plotted Points |
EPTC |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 57 | 107% | 16% | 104% | 12% |
Total | 57 | 107% | 16% | 104% | 12% |
Miscellaneous Statistics for the Samples |
EPTC |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 57 | 97% | Spiked |
Estimated Values | 9 | 15% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 59 | . | |
False Negatives | 2 | 3% | 2 out of 59 |
Not Spiked | 124 | . | |
False Positives | 2 | 2% | 2 out of 124 |
Statistics for the Plotted Points |
TEBUTHIURON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 200% | . | 200% | 0% |
>= Reporting Level | 57 | 138% | 30% | 138% | 40% |
Total | 58 | 139% | 31% | 138% | 40% |
Miscellaneous Statistics for the Samples |
TEBUTHIURON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 58 | 95% | Spiked |
Estimated Values | 13 | 21% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 3 | 5% | 3 out of 61 |
Not Spiked | 122 | . | |
False Positives | 3 | 2% | 3 out of 122 |
Statistics for the Plotted Points |
MOLINATE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 57 | 105% | 18% | 105% | 10% |
Total | 57 | 105% | 18% | 105% | 10% |
Miscellaneous Statistics for the Samples |
MOLINATE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 57 | 97% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 59 | . | |
False Negatives | 2 | 3% | 2 out of 59 |
Not Spiked | 124 | . | |
False Positives | 2 | 2% | 2 out of 124 |
Statistics for the Plotted Points |
ETHOPROPHOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 65 | 108% | 19% | 107% | 17% |
Total | 65 | 108% | 19% | 107% | 17% |
Miscellaneous Statistics for the Samples |
ETHOPROPHOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 65 | 97% | Spiked |
Estimated Values | 5 | 7% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 67 | . | |
False Negatives | 2 | 3% | 2 out of 67 |
Not Spiked | 116 | . | |
False Positives | 3 | 3% | 3 out of 116 |
Statistics for the Plotted Points |
BENFLURALIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 59 | 79% | 12% | 79% | 11% |
Total | 59 | 79% | 12% | 79% | 11% |
Miscellaneous Statistics for the Samples |
BENFLURALIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 59 | 97% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 2 | 3% | 2 out of 61 |
Not Spiked | 122 | . | |
False Positives | 2 | 2% | 2 out of 122 |
Statistics for the Plotted Points |
CARBOFURAN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 123% | 25% | 138% | 20% |
>= Reporting Level | 53 | 104% | 19% | 107% | 17% |
Total | 58 | 105% | 20% | 107% | 18% |
Miscellaneous Statistics for the Samples |
CARBOFURAN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 58 | 95% | Spiked |
Estimated Values | 58 | 95% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 3 | 5% | 3 out of 61 |
Not Spiked | 122 | . | |
False Positives | 3 | 2% | 3 out of 122 |
Statistics for the Plotted Points |
TERBUFOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 65 | 68% | 17% | 66% | 14% |
Total | 65 | 68% | 17% | 66% | 14% |
Miscellaneous Statistics for the Samples |
TERBUFOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 65 | 97% | Spiked |
Estimated Values | 1 | 1% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 67 | . | |
False Negatives | 2 | 3% | 2 out of 67 |
Not Spiked | 116 | . | |
False Positives | 2 | 2% | 2 out of 116 |
Statistics for the Plotted Points |
PROPYZAMIDE (PRONAMIDE) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 57 | 95% | 15% | 94% | 16% |
Total | 57 | 95% | 15% | 94% | 16% |
Miscellaneous Statistics for the Samples |
PROPYZAMIDE (PRONAMIDE) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 57 | 97% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 59 | . | |
False Negatives | 2 | 3% | 2 out of 59 |
Not Spiked | 124 | . | |
False Positives | 2 | 2% | 2 out of 124 |
Statistics for the Plotted Points |
DISULFOTON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 68% | 12% | 68% | 13% |
>= Reporting Level | 57 | 64% | 15% | 64% | 12% |
Total | 59 | 64% | 15% | 64% | 12% |
Miscellaneous Statistics for the Samples |
DISULFOTON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 59 | 97% | Spiked |
Estimated Values | 59 | 97% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 2 | 3% | 2 out of 61 |
Not Spiked | 122 | . | |
False Positives | 2 | 2% | 2 out of 122 |
Statistics for the Plotted Points |
PROPANIL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 66 | 112% | 19% | 111% | 22% |
Total | 66 | 112% | 19% | 111% | 22% |
Miscellaneous Statistics for the Samples |
PROPANIL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 66 | 99% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 67 | . | |
False Negatives | 1 | 1% | 1 out of 67 |
Not Spiked | 116 | . | |
False Positives | 1 | 1% | 1 out of 116 |
Statistics for the Plotted Points |
CARBARYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 23 | 115% | 20% | 112% | 24% |
>= Reporting Level | 42 | 85% | 19% | 88% | 20% |
Total | 65 | 96% | 24% | 96% | 22% |
Miscellaneous Statistics for the Samples |
CARBARYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 65 | 97% | Spiked |
Estimated Values | 65 | 97% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 67 | . | |
False Negatives | 2 | 3% | 2 out of 67 |
Not Spiked | 116 | . | |
False Positives | 3 | 3% | 3 out of 116 |
Statistics for the Plotted Points |
THIOBENCARB |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 65 | 98% | 18% | 96% | 16% |
Total | 65 | 98% | 18% | 96% | 16% |
Miscellaneous Statistics for the Samples |
THIOBENCARB |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 65 | 97% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 67 | . | |
False Negatives | 2 | 3% | 2 out of 67 |
Not Spiked | 116 | . | |
False Positives | 7 | 6% | 7 out of 116 |
Statistics for the Plotted Points |
DACTHAL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 57 | 105% | 12% | 103% | 11% |
Total | 57 | 105% | 12% | 103% | 11% |
Miscellaneous Statistics for the Samples |
DACTHAL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 57 | 97% | Spiked |
Estimated Values | 6 | 10% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 59 | . | |
False Negatives | 2 | 3% | 2 out of 59 |
Not Spiked | 124 | . | |
False Positives | 2 | 2% | 2 out of 124 |
Statistics for the Plotted Points |
PENDIMETHALIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 58 | 96% | 19% | 94% | 21% |
Total | 58 | 96% | 19% | 94% | 21% |
Miscellaneous Statistics for the Samples |
PENDIMETHALIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 58 | 97% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 60 | . | |
False Negatives | 2 | 3% | 2 out of 60 |
Not Spiked | 123 | . | |
False Positives | 2 | 2% | 2 out of 123 |
Statistics for the Plotted Points |
PROPARGITE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 59 | 78% | 25% | 77% | 25% |
Total | 59 | 78% | 25% | 77% | 25% |
Miscellaneous Statistics for the Samples |
PROPARGITE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 59 | 97% | Spiked |
Estimated Values | 4 | 7% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 2 | 3% | 2 out of 61 |
Not Spiked | 122 | . | |
False Positives | 2 | 2% | 2 out of 122 |
Statistics for the Plotted Points |
AZINPHOS-METHYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 17 | 96% | 24% | 96% | 23% |
>= Reporting Level | 48 | 78% | 18% | 77% | 19% |
Total | 65 | 83% | 21% | 82% | 22% |
Miscellaneous Statistics for the Samples |
AZINPHOS-METHYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 65 | 97% | Spiked |
Estimated Values | 65 | 97% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 67 | . | |
False Negatives | 2 | 3% | 2 out of 67 |
Not Spiked | 116 | . | |
False Positives | 2 | 2% | 2 out of 116 |
Statistics for the Plotted Points |
1RS CIS-PERMETHRIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 65 | 67% | 16% | 65% | 15% |
Total | 65 | 67% | 16% | 65% | 15% |
Miscellaneous Statistics for the Samples |
1RS CIS-PERMETHRIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 65 | 97% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 67 | . | |
False Negatives | 2 | 3% | 2 out of 67 |
Not Spiked | 116 | . | |
False Positives | 2 | 2% | 2 out of 116 |